RIO DE JANEIRO, BRAZIL - (Reuters) Brazil will soon weigh emergency-use approval for AstraZeneca’s COVID-19 vaccine after Britain gave the green light on Wednesday, December 30th, as the South American country was forced into making regulatory concessions to speed up its lagging immunization program.
Britain on Wednesday became the first country in the world to give full regulatory approval to the coronavirus vaccine developed by Oxford University and AstraZeneca.
The U.K. approval offers hope to Brazil, which has made the cheap and sturdy British vaccine a cornerstone of its widely criticized vaccine plan.
But it also highlights . . .